Biotech

The Long View: Fragile Scaling

Cutting headcount to survive the next milestone creates exposures distinct from those of growth, and most boards underestimate them.

Jun 12, 2026 4 min read members

In the foreground is a chess board with a queen patterned to resemble the UK flag. In the background there is a blurry hospital bed with an in-focus IV line.

Watchdog Wednesday: The UK’s Express Lane for Latecomers

The UK's new "notifiable trial" route can shave weeks off your timeline, but only if you sequence your jurisdictions like a chess player rather than a tourist.

Jun 10, 2026 5 min read members

Milestone Monday: A $10.5 Billion China Bet And A Missing NDA

ASCO ended a week ago. The filing and the deal structure that deserve a closer look.

Jun 8, 2026 4 min read members

Page 1 of 1

The Long View: Fragile Scaling

Watchdog Wednesday: The UK’s Express Lane for Latecomers

Milestone Monday: A $10.5 Billion China Bet And A Missing NDA